Recent News & PR

Summary

Message to Participants

N/A

Detailed Information

JOCAVIO Inc. aims to develop new technologies for cancer immunotherapy based in Kyushu, providing hope to cancer patients. We are advancing research on virus-based tumor lysis therapy, aiming for clinical development by 2026.

Unfair Advantage & Strengths

N/A

Competitors

N/A

Company Profile

事業カテゴリ

SaaS / B2Bソフトウェア, AI / データ活用, Healthcare / Biotech

本社所在地

Higashi-ku, Fukuoka, Japan

設立日

2021年8月2日

資本金

3.4億円

Employee Count

1(0)

Industry Outlook & Trends for JOCAVIO Inc.

In the B2B SaaS and software market where JOCAVIO Inc. operates, rapid growth continues to be driven by corporate digital transformation (DX). Beyond general-purpose tools, specialized Vertical SaaS that automates industry-specific workflows is rising. Furthermore, integration with AI is transforming SaaS into intelligent platforms. To address global labor shortages, innovative solutions like those provided by JOCAVIO Inc. continue to grow as an indispensable business infrastructure.

🔒

VPO Investor Pro Features

You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:

🎬

Elevator & Full Pitch Video

Watch full presentations with English/Japanese subtitles.

📊

AI Quick Report & Valuation

Get AI-driven assessment scores on market, product, and traction.

📅

Priority Challenges & Hiring

Access core corporate bottlenecks and current hiring plans.

📝

Full Transcripts

Read full pitch dialogue in both English and Japanese.

📈

Financials & Exit Strategy

Unlock IPO/M&A timelines and debt/equity plans.

👥

Advisors & Key Members

View internal team details and advisory board configurations.

Create Free Account & View Details

JOCAVIO Inc.